KLRK1 and tuberculosis: Among TB patients, we found a decline in antigen-induced NKG2D mRNA expression during the intensive phase of chemotherapy, for both M. bovis BCG (p = 0.002) and anti-CD3 stimulation (p = 0.001), in patients who were subsequently successfully cured (Figure 4B).